235 related articles for article (PubMed ID: 21595663)
1. Prolactin level is significantly elevated in lesional skin of patients with psoriasis.
El-Khateeb EA; Zuel-Fakkar NM; Eid SM; Abdul-Wahab SE
Int J Dermatol; 2011 Jun; 50(6):693-6. PubMed ID: 21595663
[TBL] [Abstract][Full Text] [Related]
2. IL-10 levels are decreased in psoriatic lesional skin as compared to the psoriatic lesion-free and normal skin suction blister fluids.
Mussi A; Bonifati C; Carducci M; Viola M; Tomaselli R; Sacerdoti G; Fazio M; Ameglio F
J Biol Regul Homeost Agents; 1994; 8(4):117-20. PubMed ID: 7660853
[TBL] [Abstract][Full Text] [Related]
3. Serum and tissue expression of transforming growth factor beta 1 in psoriasis.
Zaher H; Shaker OG; EL-Komy MH; El-Tawdi A; Fawzi M; Kadry D
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):406-9. PubMed ID: 19175705
[TBL] [Abstract][Full Text] [Related]
4. Vascular adhesion protein-1 (VAP-1) is overexpressed in psoriatic patients.
Madej A; Reich A; Orda A; Szepietowski JC
J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):72-8. PubMed ID: 17207171
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis.
Benoit S; Toksoy A; Ahlmann M; Schmidt M; Sunderkötter C; Foell D; Pasparakis M; Roth J; Goebeler M
Br J Dermatol; 2006 Jul; 155(1):62-6. PubMed ID: 16792753
[TBL] [Abstract][Full Text] [Related]
6. Comparison of plasma prekallikrein levels in human skin blister and chamber fluids from volunteer subjects and psoriatic patients.
Thomas NK; Marshman G; Worthy K; Burton J; Bhoola KD
Agents Actions Suppl; 1992; 38 ( Pt 3)():397-404. PubMed ID: 1462873
[TBL] [Abstract][Full Text] [Related]
7. Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy.
Komatsu N; Saijoh K; Kuk C; Shirasaki F; Takehara K; Diamandis EP
Br J Dermatol; 2007 May; 156(5):875-83. PubMed ID: 17459012
[TBL] [Abstract][Full Text] [Related]
8. Soluble intercellular adhesion molecule-1 and procollagen III peptide are reliable markers of disease severity in psoriasis.
Ameglio F; Bonifati C; Carducci M; Alemanno L; Sacerdoti G; Fazio M
Acta Derm Venereol Suppl (Stockh); 1994; 186():19-20. PubMed ID: 7915482
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum levels of interleukin 21 are associated with disease severity in patients with psoriasis.
He Z; Jin L; Liu ZF; Hu L; Dang EL; Feng ZZ; Li QJ; Wang G
Br J Dermatol; 2012 Jul; 167(1):191-3. PubMed ID: 22356196
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor in psoriasis: an indicator of disease severity and control.
Nofal A; Al-Makhzangy I; Attwa E; Nassar A; Abdalmoati A
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):803-6. PubMed ID: 19309427
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide and malondialdehyde levels in plasma and tissue of psoriasis patients.
Sikar Aktürk A; Özdoğan HK; Bayramgürler D; Çekmen MB; Bilen N; Kıran R
J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):833-7. PubMed ID: 21749467
[TBL] [Abstract][Full Text] [Related]
12. Relationship between smoking-induced oxidative stress and the clinical severity of psoriasis.
Attwa E; Swelam E
J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):782-7. PubMed ID: 21039915
[TBL] [Abstract][Full Text] [Related]
13. Serum and tissue levels of IL-17 in different clinical subtypes of psoriasis.
Yilmaz SB; Cicek N; Coskun M; Yegin O; Alpsoy E
Arch Dermatol Res; 2012 Aug; 304(6):465-9. PubMed ID: 22426986
[TBL] [Abstract][Full Text] [Related]
14. IL-1 alpha, IL-1 beta and psoriasis: conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skin.
Bonifati C; Carducci M; Mussi A; D'auria L; Ameglio F
J Biol Regul Homeost Agents; 1997; 11(4):133-6. PubMed ID: 9582612
[TBL] [Abstract][Full Text] [Related]
15. Proteolytic activity and expression of the 20S proteasome are increased in psoriasis lesional skin.
Henry L; Le Gallic L; Garcin G; Coux O; Jumez N; Roger P; Lavabre-Bertrand T; Martinez J; Meunier L; Stoebner PE
Br J Dermatol; 2011 Aug; 165(2):311-20. PubMed ID: 21740404
[TBL] [Abstract][Full Text] [Related]
16. High levels of hyaluronate in suction blister fluid from active psoriatic lesions.
Lundin A; Engström-Laurent A; Michaëlsson G; Tengblad A
Br J Dermatol; 1987 Mar; 116(3):335-40. PubMed ID: 3567072
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of interleukin-8, tumor necrosis factor-α and γ-interferon in Egyptian psoriatic patients and correlation with disease severity.
Abdel-Hamid MF; Aly DG; Saad NE; Emam HM; Ayoub DF
J Dermatol; 2011 May; 38(5):442-6. PubMed ID: 21352285
[TBL] [Abstract][Full Text] [Related]
18. Expression of p53 in lesions and unaffected skin of patients with plaque-type and guttate psoriasis: a quantitative comparative study.
Yazici AC; Karabulut AA; Ozen O; Ekşioğlu M; Ustün H
J Dermatol; 2007 Jun; 34(6):367-74. PubMed ID: 17535401
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity.
Jacob SE; Nassiri M; Kerdel FA; Vincek V
Mediators Inflamm; 2003 Oct; 12(5):309-13. PubMed ID: 14760939
[TBL] [Abstract][Full Text] [Related]
20. K16 expression in uninvolved psoriatic skin: a possible marker of pre-clinical psoriasis.
Bhawan J; Bansal C; Whren K; Schwertschlag U;
J Cutan Pathol; 2004 Aug; 31(7):471-6. PubMed ID: 15239676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
